We're gearing up to attend the RNA Leaders USA Congress from September 4 - 5 in San Diego, CA. This conference is an essential gathering for professionals dedicated to the future of mRNA therapies. We look forward to speaking on our advancements and learning from the wealth of knowledge presented by experts in the field.
ReCode Therapeutics’ Post
More Relevant Posts
-
mRNAs can be instructed to produce any protein in the body, using the cells own natural machinery to potentially treat diseases and prevent infections. This opens up a whole new way to flexibly and successfully treat and manage diseases, ranging from vaccine development to therapeutics. Listen to Dr. Aditi Mehta describe the science behind mRNA synthesis and RNA delivery vehicles. Merck Life Science #mRNA #Innovation
Harnessing the huge potential of mRNA technology
To view or add a comment, sign in
-
mRNAs can be instructed to produce any protein in the body, using the cells own natural machinery to potentially treat diseases and prevent infections. This opens up a whole new way to flexibly and successfully treat and manage diseases, ranging from vaccine development to therapeutics. Listen to Dr. Aditi Mehta describe the science behind mRNA synthesis and RNA delivery vehicles. MilliporeSigma #mRNA #Innovation
Harnessing the huge potential of mRNA technology
To view or add a comment, sign in
-
Do you have research on exploring the therapeutic effects of transient CAR/TCR expression using mRNA delivery? Abstract topic #4 “CAR/TCR mRNA Therapies” is the right choice for YOU! Do not miss the chance to take the stage at #ICLE2025: https://bit.ly/3WCHJgf #lymphocytes #lymphocytesengineering #CARTcells
To view or add a comment, sign in
-
Read our newest work on ER-to-Golgi transport of mucin-2, now deposited at the bioRxiv preprint server. in this paper, we show how COPII-coated vesicle-mediated transport of very large mucin-2 is facilitated by enlargement of the vesicles making use of anxiliary proteins TANGO1, cTAGE5 and KLHL12. We also show how inhibition of ER-to-Golgi trafficking of mucin-2 is associated with ER stress reminiscent of ER stress observed in Inflammatory Bowel Disease using cell assays and clinical patient mRNA data. Access the paper here: https://lnkd.in/eZ7_JxuP
To view or add a comment, sign in
-
A few months ago, Christine Boswell and Elaine Peters "challenged" (a.k.a. permitted) me to share a few thoughts--and metaphors--on the mRNA world at the BioPhorum ATMP conference. But as much fun as it would be to read an exhaustive outline of my presentation, I chose instead to share the one takeaway that I'd argue rises above the others--especially as I see more crossover happening between the cell-based CGT and mRNA fields. In the following article, I share a few learnings from outside the mRNA universe that showcase just how much potential we have to learn from the #advancedtherapies that have come before our mRNA therapies.
To view or add a comment, sign in
-
Adjunct Assistant Professor in Electrical and Computer Engineering (ECE) at Georgia Institute of Technology
TGF-βR2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue https://lnkd.in/guNHktE8
mRNA Therapy shows promise for COVID-19 and flu damage. University of Pennsylvania scientists have identified a promising pathway involving vascular endothelial growth factor α (Vegfa) and the TGF-β receptor 2 (TGF-βR2) for repairing lung damage caused by respiratory infections like COVID-19 and influenza. By delivering Vegfa using lipid nanoparticles (LNPs), they observed enhanced repair of damaged blood vessels in animal models. This mRNA therapy holds the potential for improving lung recovery after viral infections and may pave the way for new treatments for lung injuries. Read more: https://lnkd.in/eGYeYJP8 #mrna #covid #lunginjury #therapeutic #medical
To view or add a comment, sign in
-
John Matthews, our Chief Medical Officer, speaks on the state of our cystic fibrosis research pipeline: "Our inhaled CFTR mRNA therapy is optimized to reach the correct cells in the lungs and instruct them to make a functional version of the CFTR protein. This would represent an exciting step in developing a successful therapy for all CF patients.” This development addresses a critical gap in #CF treatment, particularly for Class I #CFTR mutations where no protein is produced. #CysticFibrosis #InnovationInHealthcare #ReCodeTherapeutics
To view or add a comment, sign in
-
Have you read Anna Rose Welch's most recent article, "A "Hot Take" On mRNA Scale-Up ? Anna is writing a multi-part “mini-series” of RNA industry “Hot Takes,” She shares several aspects that jumped out at her from the BioPhorum ATMP Event in March. Here's "Hot Take #1" - There Are More Pitfalls In Scaling #mRNA/ #RNA Than We Admit. Read more here: https://lnkd.in/gzpUamAZ #mrna #rna #scaleup #ATMP
A "Hot Take" On mRNA Scale-Up
advancingrna.com
To view or add a comment, sign in
-
📣 New article published by the team of Silvia Gregori! The review authored by Konstantina Morali, Gloria Giacomello, Michela Vuono and Silvia Gregori provides an overview of current knowledge on the role of tolerogenic dendritic cells (tolDC) in health and disease. The review is focused on (i) IL-10 production, (ii) functional characterization of in vitro generated tolDC, (iii) molecular and metabolic changes occurring in tolDC induced by tolerogenic agents, (iv) clinical applications of tolDC-based therapy, and on (v) new perspectives in the generation of effective tolDC. Congratulations to all co-authors! Link to the paper: https://lnkd.in/dfE-nWcz #HaDEA, #EU, #immunotherapy, #tolerogenicdendriticcells
FEBS Press
febs.onlinelibrary.wiley.com
To view or add a comment, sign in
-
Unlocking the mysteries of single-cell data! #Decipher a novel computational pipeline to extract context-specific mechanistic insights from single-cell profiles. 🎯 It builds integrated cell signaling networks in a data-driven manner, uncovering key drivers of disease and cellular responses to therapies like mRNA vaccines. This could lead to faster drug discovery & personalized medicine! Quick Read: https://lnkd.in/gVXMdj4m #bioinformatics #singlecell #rnaseq #machinelearning #sciencenews
To view or add a comment, sign in
14,928 followers